Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Current Cancer Drug Targets|July 24, 2013
Small molecule inhibitors of multidrug resistance gene (MDR1) expression: preclinical evaluation and mechanisms of actionSofia A Santos, Alexandra PauloEuropean Journal of Medicinal Chemistry|August 22, 2015
Exploring the 3-piperidin-4-yl-1H-indole scaffold as a novel antimalarial chemotypeSofia A Santos, Amanda K Lukens, Lis Coelho, et al.Journal of Medicinal Chemistry|March 29, 2014
Bis-alkylamine Indolo[3,2-b]quinolines as hemozoin ligands: implications for antimalarial cytostatic and cytocidal activitiesAlexandra Paulo, Marta Figueiras, Marta Machado, et al.World Journal of Gastroenterology|April 26, 2007
Hepatic abscess induced by foreign body: case report and literature reviewSofia A Santos, Sara C F Alberto, Elsa Cruz, et al.Bioconjugate Chemistry|May 7, 2014
Monoalkoxy BODIPYs--a fluorophore class for bioimagingAlexandra M Courtis, Sofia A Santos, Yinghua Guan, et al.Bioorganic & Medicinal Chemistry Letters|August 31, 2010
Bis-alkylamine quindolone derivatives as new antimalarial leadsJoão Lavrado, Kaamil Gani, Pedro A Nobre, et al.Bioorganic & Medicinal Chemistry|March 2, 2015
N10,N11-di-alkylamine indolo[3,2-b]quinolines as hemozoin inhibitors: design, synthesis and antiplasmodial activityMarta Figueiras, Lis Coelho, Kathryn J Wicht, et al.ACS Infectious Diseases|February 19, 2019
The Adaptive Proline Response in P. falciparum Is Independent of PfeIK1 and eIF2α SignalingLola Fagbami, Amy A Deik, Kritika Singh, et al.Plos One|May 30, 2015
Targeting KRAS Oncogene in Colon Cancer Cells with 7-Carboxylate Indolo[3,2-b]quinoline Tri-Alkylamine DerivativesHugo Brito, Ana Cláudia Martins, João Lavrado, et al.Nature Communications|August 25, 2022
Elucidating the path to Plasmodium prolyl-tRNA synthetase inhibitors that overcome halofuginone resistanceMark A Tye, N Connor Payne, Catrine Johansson, et al.Pageof 2